Molecular features associated with response to combination therapy with enasidenib (ENA) plus azacitidine (AZA) in newly diagnosed IDH2-mutated acute myeloid leukemia (AML) Meeting Abstract
| Authors: | Risueño, A.; See, W. L.; DiNardo, C. D.; Döhner, H.; Stein, E.; Fathi, A. T.; Vyas, P.; Quek, L.; Prebet, T.; Gandhi, A. K.; Hasan, M. |
| Abstract Title: | Molecular features associated with response to combination therapy with enasidenib (ENA) plus azacitidine (AZA) in newly diagnosed IDH2-mutated acute myeloid leukemia (AML) |
| Meeting Title: | 64th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 140 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2022 Dec 10-13 |
| Meeting Location: | New Orleans, LA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2022-11-15 |
| Start Page: | 732 |
| End Page: | 734 |
| Language: | English |
| ACCESSION: | WOS:000893223200301 |
| DOI: | 10.1182/blood-2022-158967 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract -- Source: Wos |
